Stocks

Wall Street Bulls Look Optimistic About IonQ (IONQ): Should You Buy?

Published October 30, 2024

When it comes to making decisions about buying, selling, or holding a stock, many investors turn to analyst recommendations for guidance. The ratings and comments from brokerage analysts can have a significant influence on stock prices, but it's important to question their true value and reliability.

In this context, let's examine what analysts on Wall Street are saying about IonQ, Inc. (IONQ) before delving into how to interpret their recommendations effectively.

Currently, IonQ has an average brokerage recommendation (ABR) of 2.00, which falls on a scale from 1 to 5, where 1 means Strong Buy and 5 signifies Strong Sell. This ABR is determined by the recommendations made by five brokerage firms. An ABR of 2.00 suggests that analysts generally recommend buying the stock.

Out of the five recommendations that contribute to this ABR, two are classified as Strong Buy and one as Buy. This translates to 40% of the recommendations being Strong Buy and 20% being categorized as Buy.

Understanding Brokerage Recommendations for IONQ

While the ABR indicates a favorable outlook for IonQ, it may not be wise to base your investment decisions solely on this average. Research has shown that brokerage recommendations often do not effectively guide investors toward stocks with the highest potential for price increases.

Why is that the case? The conflict of interest that brokerage firms have in the stocks they analyze often leads analysts to demonstrate a positive bias in their ratings. In fact, studies have revealed that for every recommendation to 'Strong Sell', there are typically five recommendations of 'Strong Buy'.

This means that analysts may not always be aligned with the interests of individual investors, which can skew their predictions about a stock's direction. Hence, using ABR as a validation tool for your research or other indicators might provide more value.

One such reliable tool is the Zacks Rank, a proprietary system that classifies stocks into five categories ranging from Zacks Rank #1 (Strong Buy) to #5 (Strong Sell), based on a solid track record of predicting near-term price performance. When you cross-reference the Zacks Rank with the ABR, it can greatly assist in formulating a profitable investment strategy.

Distinguishing ABR from Zacks Rank

Despite both the ABR and Zacks Rank using a similar 1 to 5 scale, they represent different evaluation methods.

The ABR is calculated based solely on brokerage recommendations and is often presented as a decimal (e.g., 1.28). In contrast, the Zacks Rank is a quantitative model that leverages the power of earnings estimate revisions and is expressed in whole numbers.

Historically, analysts working for brokerage firms tend to offer overly optimistic recommendations due to their companies' vested interests. Thus, these analysts often provide positive ratings that might not reflect the underlying research, which can mislead investors.

The Zacks Rank, however, relies on earnings estimate revisions and is closely tied to stock price movements. This feature makes it a timely indicator, adapting quickly to changing business conditions.

Should You Invest in IONQ?

Looking closely at IonQ's earnings estimates, we find that the Zacks Consensus Estimate for this year has remained steady at -$0.84 over the past month.

The steady views from analysts regarding the company's earnings potential, reflected in an unchanged consensus estimate, suggest that IonQ may not stray far from the broader market's performance in the immediate future.

The size of recent changes in the consensus estimate, among other factors, currently provides IonQ with a Zacks Rank of #3 (Hold). For investors interested in exploring stocks with the highest potential, checking the full list of Zacks Rank #1 (Strong Buy) stocks can be advantageous.

In conclusion, while the average brokerage recommendation for IonQ leans towards a Buy, it would be prudent for investors to approach this recommendation with caution.

IonQ, Investment, Analysts